Applied Therapeutics Stock (NASDAQ: APLT) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 25.00 / 2.36M |
Day Range | - - - |
52 Wk Range | 1.79 - 9.39 |
Market Cap | $883.17M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 67 |
Short Interest | 9.51% |
Days to Cover | 10.72 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Applied Therapeutics (NASDAQ:APLT) through any online brokerage.
Other companies in Applied Therapeutics’s space includes: Immunome (NASDAQ:IMNM), 89bio (NASDAQ:ETNB), Replimune Group (NASDAQ:REPL), Arcutis Biotherapeutics (NASDAQ:ARQT) and Tango Therapeutics (NASDAQ:TNGX).
Applied Therapeutics has a consensus price target of $11.04.
The stock price for Applied Therapeutics (NASDAQ: APLT) is $7.69 last updated September 23, 2024 at 7:54 PM EDT.
There are no upcoming dividends for Applied Therapeutics.
Applied Therapeutics’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Applied Therapeutics.
Applied Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.